Safety and immunogenicity of DNA omicron booster Alveavaxv12 in Ad26COV2Svaccinated adults

dc.article.end-page9en
dc.article.start-page1en
dc.citation.doi10.1016/J.ISCI.2025.113970en
dc.contributor.authorM Schonsen
dc.contributor.authorTobias Odendahlen
dc.contributor.authorJames Smithen
dc.contributor.authorKyle Fishen
dc.contributor.authorPenelope Mooreen
dc.contributor.authorE et alen
dc.date.accessioned2026-02-24T19:40:12Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2589-0042en
dc.identifier.urihttps://hdl.handle.net/10539/48301
dc.journal.titleSafety and immunogenicity of DNA omicron booster Alveavaxv12 in Ad26COV2Svaccinated adultsen
dc.journal.volume28en
dc.titleSafety and immunogenicity of DNA omicron booster Alveavaxv12 in Ad26COV2Svaccinated adultsen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
3.7 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client